90
Views
20
CrossRef citations to date
0
Altmetric
Original Research

High-potency statins but not all statins decrease the risk of new-onset osteoporotic fractures: a nationwide population-based longitudinal cohort study

, , , &
Pages 159-165 | Published online: 18 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Wei-Jen Chen, Hanoch Livneh, Hsin-Hua Li, Yu-Han Wang, Ming-Chi Lu, Tzung-Yi Tsai & Kuei-Yu Chien. (2023) Use of Chinese Herbal Medicine Was Related to Lower Risk of Osteoporotic Fracture in Sarcopenia Patients: Evidence from Population-Based Health Claims. International Journal of General Medicine 16, pages 3345-3354.
Read now
Chen-Yu Huang, Wen-Hsun Chang, Hsin-Yi Huang, Chao-Yu Guo, Yiing-Jenq Chou, Nicole Huang, Wen-Ling Lee & Peng-Hui Wang. (2020) Subsequent Development of Epithelial Ovarian Cancer After Ovarian Surgery for Benign Ovarian Tumor: A Population-Based Cohort Study. Clinical Epidemiology 12, pages 637-649.
Read now

Articles from other publishers (18)

Andrey Svec & Adriana Adameova. (2022) Facts and ideas on statins with respect to their lipophilicity: a focus on skeletal muscle cells and bone besides known cardioprotection. Molecular and Cellular Biochemistry 478:8, pages 1661-1667.
Crossref
Tsung-Kun Lin, Lung-Fa Pan & Gwo-Ping Jong. (2023) Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study’. Annals of the Rheumatic Diseases 82:6, pages e141-e141.
Crossref
Susanne Trost, Nolawit Tesfaye & Tasma Harindhanavudhi. (2023) The interplay between bone and heart health as reflected in medication effects: A narrative review. Women's Health 19, pages 174550572311655.
Crossref
Mengxin Xiong, Yaojun Xue, Wei Zhu, Ali Deng, Zhangkui Tan, Guangwen Zhou & Nan Xiang. (2022) Comparative efficacy and safety of statins for osteoporosis: a study protocol for a systematic review and network meta-analysis. BMJ Open 12:5, pages e054158.
Crossref
C. Minichsdorfer, T. Fuereder, M. Leutner, C.F. Singer, S. Kacerovsky-Strobl, D. Egle, R. Greil, M. Balic, F. Fitzal, G. Pfeiler, S. Frantal, R. Bartsch & M. Gnant. (2022) Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18. ESMO Open 7:2, pages 100426.
Crossref
Michael Leutner, Caspar Matzhold, Luise Bellach, Carola Deischinger, Jürgen Harreiter, Stefan Thurner, Peter Klimek & Alexandra Kautzky-Willer. (2021) Response to: ‘Association between osteoporosis and statins therapy’ by Lai. Annals of the Rheumatic Diseases 80:11, pages e181-e181.
Crossref
Shih-Wei Lai. (2021) Association between osteoporosis and statins therapy. Annals of the Rheumatic Diseases 80:11, pages e180-e180.
Crossref
Yi-Sheng Liou, Tsung-Kun Lin, Hung-Yi Chen & Gwo-Ping Jong. (2021) Medications associated with fracture risk in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 80:9, pages e140-e140.
Crossref
Kyoung Jin Kim, Jimi Choi, Ji Yoon Kim, Jae Hyun Bae, Kyeong Jin Kim, Hee Young Kim, Hye Jin Yoo, Ji A Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Sin Gon Kim & Nam Hoon Kim. (2021) Statin Therapy and the Risk of Osteoporotic Fractures in Patients with Metabolic Syndrome: a Nested Case-Control Study. Journal of Lipid and Atherosclerosis 10:3, pages 322.
Crossref
凯 门. (2021) Application of Statins in Chronic Obstructive Pulmonary Disease. Advances in Clinical Medicine 11:12, pages 6183-6188.
Crossref
Nelson B. Watts. 2021. Marcus and Feldman's Osteoporosis. Marcus and Feldman's Osteoporosis 1061 1068 .
Yao Guo, Jianzhong Huo, Dou Wu, Haihu Hao, Xinghua Ji, Enzhe Zhao, Boyuan Nie & Qiang Liu. (2020) Simvastatin inhibits the adipogenesis of bone marrow‑derived mesenchymal stem cells through the downregulation of chemerin/CMKLR1 signaling. International Journal of Molecular Medicine 46:2, pages 751-761.
Crossref
Rebecca Rothe, Sabine Schulze, Christin Neuber, Sandra Hauser, Stefan Rammelt & Jens Pietzsch. (2020) Adjuvant drug-assisted bone healing: Part III – Further strategies for local and systemic modulation. Clinical Hemorheology and Microcirculation 73:3, pages 439-488.
Crossref
Michael Leutner, Caspar Matzhold, Luise Bellach, Carola Deischinger, Jürgen Harreiter, Stefan Thurner, Peter Klimek & Alexandra Kautzky-Willer. (2019) Diagnosis of osteoporosis in statin-treated patients is dose-dependent. Annals of the Rheumatic Diseases 78:12, pages 1706-1711.
Crossref
Tamer Sallam, Yin Tintut & Linda L. Demer. (2019) Regulation of calcific vascular and valvular disease by nuclear receptors. Current Opinion in Lipidology 30:5, pages 357-363.
Crossref
W.-J. Hong, W. Chen, K.-J. Yeo, P.-H. Huang, D.-Y. Chen & J.-L. Lan. (2019) Increased risk of osteoporotic vertebral fracture in rheumatoid arthritis patients with new-onset cardiovascular diseases: a retrospective nationwide cohort study in Taiwan. Osteoporosis International 30:8, pages 1617-1625.
Crossref
W.-J. Chen, H. Livneh, M.-H. Hsieh, C.-C. Yeh, M.-H. Yeh, M.-C. Lu, J.-T. Chien & T.-Y. Tsai. (2019) Association of use of Chinese herbal medicines and the risk of fracture in patients with osteoporosis: a population-based cohort study. Osteoporosis International 30:4, pages 807-815.
Crossref
I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova & O. V. Kosmatova. (2019) Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength. Rational Pharmacotherapy in Cardiology 15:1, pages 69-76.
Crossref